Global Hospital & Biosimilars Health System Director East

Role Summary

Global Hospital & Biosimilars Health System Director East is responsible for leading pricing and contracting discussions with Hospital & Biosimilars Key Accounts, engaging executive and administrative stakeholders, and coordinating with HQ functions to support biosimilars pricing, contracts, and formulary access. The role develops regional hospital and biosimilar strategies, drives pull-through and contract execution with AHS and field teams, and collaborates across cross-functional teams to maximize opportunities within assigned HSD accounts, including large community ONC clinics, NCI/academic institutions, and oncology service lines within large hospital systems and IDNs. Geography includes New York, Maine, Vermont, New Hampshire, Massachusetts, Connecticut, Rhode Island, Virginia, North Carolina, West Virginia, Ohio, New Jersey, Delaware, Maryland, and Pennsylvania.

Responsibilities

• Appropriate communication and collaboration with cross-functional colleagues to support effective pricing/contracting strategy and discussions with Hospital & Biosimilars Key Accounts.
• Develop and execute focused and strategic account plans for all assigned accounts, with emphasis on compliant contracting discussions and contract pull-through.
• Engage appropriate executive and administrative level personnel within HSD accounts with respect to pricing/value messages in support of the full Hospital & Biosimilars portfolio.
• Support the development and execution of contracting strategy for the full biosimilars portfolio by representing the needs/perspectives of HSD accounts to HQ-based functions.
• Comply with all corporate policies and procedures while conducting job activities with integrity and high standards of business conduct.

Qualifications

• Required: 8 years of progressive experience in pharmaceutical sales, medical affairs, and/or corporate account management with customer-facing responsibility.
• Required: Includes a minimum 3–5 years of direct biosimilars and generic sterile injectables experience, including buy-and-bill strategies, and knowledge of regulatory pathways (FDA, EMA, Health Canada) and interchangeability requirements.
• Required: Manufacturing and quality standards for biologics and generic sterile injectables, including comparability exercises; commercialization strategies, market access, IDN and alternate site clinic negotiations, and formulary inclusion for biosimilars; pharmacovigilance and post-market safety monitoring.
• Preferred: Oncology and/or Immunology & Inflammation therapeutic area expertise.
• Preferred: Proven success engaging Academic Medical Centers, IDNs, and large group practice community accounts.
• Preferred: Strong understanding of the evolving US healthcare landscape and impact on organized provider accounts; strong financial acumen to deliver complex pricing/value messages in a compliant fashion; demonstrated ability to engage executive/administrative level personnel at large accounts and deliver customer impact; strategic thinking and ability to develop and monitor stakeholder business plans; project management skills; cross-functional leadership experience.

Education

• Bachelor’s Degree required
• MBA or relevant graduate degree preferred

Skills

• Business Acumen: Knowledge of the evolving healthcare market; ability to manage executive-level relationships with key accounts; account management and negotiation skills.
• Financial Acumen
• Market and Business Strategy
• Account and Customer Management
• Functional Knowledge
• Data Analytics and Interpretations
• Strategic Perspective and Planning
• Critical and Analytical Thinking
• Execution and Measurement of Outcomes
• Relationship Management: Networking, Stakeholder Management, Influencing and Leading without Authority
• Driving Ownership Culture: Accountability, Compliance, adaptability to change, and proactive change leadership